LENZ Therapeutics, Inc.

NASDAQ:LENZ

Biotechnology

Healthcare
$3.34 -6.62%

-$0.42 today

Market cap
$104.94M
Beta
1.47
P/E (TTM)
-1.7
EPS (TTM)
-$3.48
52W Low $5.85High $50.40

Volume 0.64M

Average 0.89M

Balance Sheet

Inspect the capital base behind the business.

Assets

$305.88M

FY 2025 · Annual

+42.1% YoY

Liabilities

$21.54M

FY 2025 · Annual

+92.0% YoY

Equity

$284.34M

FY 2025 · Annual

+39.3% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents18.31M44.44M35.14M20.16M25.18M
Short-term Investments0220.5M30.65M188.87M267.17M
Net Receivables00002.43M
Inventory00000
Other Current Assets16K2.2M1.45M114K(2.43M)
Total Current Assets18.32M46.64M67.24M211.92M292.35M
Property, Plant & Equipment (Net)10K279K372K1.99M1.92M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets2K31K2.76M1.4M2.54M
Total Non-current Assets12K310K3.13M3.39M4.46M
Total Assets18.34M46.95M70.38M215.3M305.88M
Account Payables460K4.76M5.71M4.26M4.17M
Short-term Debt00000
Tax Payables0347K000
Deferred Revenue00000
Other Current Liabilities00000
Total Current Liabilities1.25M9.5M18.51M10.41M21.19M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities31.3M61.47M144.38M00
Total Non-current Liabilities31.3M61.62M144.57M814K350K
Total Liabilities32.55M71.12M163.09M11.22M21.54M
Common Stock1K10K10K1K1K
Retained Earnings(14.47M)(25.28M)(95.25M)(145.01M)(227.14M)
Accumulated OCI0(1.05M)6K196K242K
Other Stockholders Equity00000
Minority Interest00000
Total Equity(14.21M)(24.17M)(92.71M)204.08M284.34M
Total Debt0250K329K1.38M815K
Net Debt(18.31M)(44.19M)(34.81M)(18.78M)(24.36M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$24.8M
Short-term Investments$233.6M
Receivables$343.0K
Inventory$3.5M
Other Current$6.1M
Total Current Assets$268.4M
PP&E (Net)$1.7M
Other Non-current$2.5M
Total Non-current Assets$4.2M
Total Assets$272.5M

Analysis

Selected assets total $272.5M for Latest. The largest visible component is Short-term Investments at $233.6M, about 85.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 5, 2026
SC 13GSC 13G filingNov 4, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
10-QQuarterly reportNov 3, 2026
4Statement of changes in beneficial ownershipNov 2, 2026

How much cash does LENZ have?

LENZ Therapeutics, Inc. (LENZ) reported $25.18M in cash and equivalents in fiscal 2025.

How much debt does LENZ carry?

LENZ Therapeutics, Inc. (LENZ) reported $815,000.00 of total debt, with net debt of -$24.36M.